Low prevalence of drug resistance transmitted virus in HIV type 1-infected ARV-naive patients in cambodia

AIDS Research and Human Retroviruses

Volumn 25, Issue 5, 2009, Pages 543-545

  Janin, Nouhin ^a   Sopheak, Ngin ^a   Regis, Martin P ^a   Olivier, Marcy ^b   Sim, Kruy L ^c   Frederic, Ariey ^a   Martine, Peeters ^d   Marie Laure, Chaix ^e   Ahidjo, Ayouba ^d   Eric, Nerrienet ^a,f  

^a INSTITUTE OF TECHNOLOGY OF CAMBODIA   (Cambodia)

^b Swiss Red Cross   (Cambodia)

^c Calmette Hospital   (Cambodia)

^d UNIVERSITÉ DE MONTPELLIER   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; NEVIRAPINE;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CAMBODIA; CD4 LYMPHOCYTE COUNT; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEASE GENE; REVERSE TRANSCRIPTASE GENE; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

ADULT; AMINO ACID SUBSTITUTION; CAMBODIA; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 66149190808     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0305     Document Type: Article

References (16)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853- 860.
2. Ferradini L, Laureillard D, Prak N, et al.: Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 2007;21(17):2293-2301.
3. Janssens B, Raleigh B, Soeung S, et al.: Effectiveness of highly active antiretroviral therapy in HIV-positive children: Evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007;120(5):e1134-1140.
4. Ly N, Recordon-Pinson P, Phoung V, et al.: Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to an-tiretroviral drugs. AIDS Res Hum Retroviruses 2005;21(11): 971-976.
5. Hirt D, Urien S, Ekouevi D, et al.: Population pharmacoki-netics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther 2009; 85(2):182-189.
6. Rouet F, Chaix ML, Nerrienet E, et al.: Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr 2007;45(4):380-388.
7. Menu E, Reynes JM, Muller-Trutwin MC, et al.: Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20(5):481-487.
8. Ananworanich J, Phanuphak N, de Souza M, et al.: Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr 2008;49(2): 151-155.
9. Lan NT, Recordon-Pinson P, Hung PV, et al.: HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01-AE and presence of major resistance mutations to antiretroviral drugs. AIDS Res Hum Retroviruses 2003;19(10): 925-928.
10. Shafer RW, Rhee SY, and Bennett DE: Consensus drug resistance mutations for epidemiological surveillance: Basic principles and potential controversies. Antivir Ther 2008; 13(Suppl 2):59-68.
11. Tee KK, Kamarulzaman A, and Ng KP: Short communication: Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses 2006;22(2):121-124.
12. Sungkanuparph S, Sukasem C, Manosuthi W, Wiboonchuti-kul S, Piyavong B, and Chantratita W: Tipranavir resistance associated mutations in protease inhibitor-naive patients with HIV-1 subtype A=E infection. J Clin Virol 2008;43(3):284-286.
13. Zhong P, Pan Q, Ning Z, et al.: Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 2007;23(7):847-856.
14. Shekelle P, Maglione M, Geotz MB, et al.: Antiretroviral (ARV) drug resistance in the developing world. Evid Rep Technol Assess (Full Rep) 2007:(156):1-74.
15. Vergne L, Stuyver L, Van Houtte M, Butel C, Delaporte E, and Peeters M: Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. J Clin Virol 2006;36(1):43-49.
16. Sirivichayakul S, Phanuphak P, Pankam T, et al.: HIV drug resistance transmission threshold survey in Bangkok, Thailand. Antivir Ther 2008;13(Suppl 2):109-113.